http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107879916-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C46-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C50-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C46-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2017-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107879916-B |
| titleOfInvention | Emodin type anthraquinone Hedyanthraquinone B and preparation method and application thereof |
| abstract | The invention provides an emodin type anthraquinone B (1, 6-dihydroxy-2, 5-dimethoxy-9, 10-anthraquinone) shown in formula (I) and a preparation method thereof, the emodin type anthraquinone B has simple extraction, separation and purification methods, definite tumor cell activity inhibition and potential development value as an antitumor drug, and the chemical structure of the compound is confirmed by the wave spectrum data, so that optical isomers do not exist, and the potential risk of the optical isomers can be avoided. |
| priorityDate | 2017-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.